Tamoxifen, screening and new oestrogen receptor modulators
- 30 June 2001
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Obstetrics & Gynaecology
- Vol. 15 (3) , 365-380
- https://doi.org/10.1053/beog.2001.0182
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- The effect of tamoxifen on endometrial thickness and endometrial histologyEuropean Journal Of Cancer, 2000
- Endometrial Histopathology in 700 Patients Treated with Tamoxifen for Breast CancerGynecologic Oncology, 2000
- Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60Obstetrics & Gynecology, 2000
- Tamoxifen and the uterusEuropean Journal Of Cancer, 1998
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- A realistic clinical perspective of tamoxifen and endometrial carcinogenesisEuropean Journal Of Cancer, 1996
- Endometrial CarcinomaNew England Journal of Medicine, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996